Antiphospholipid syndrome. The clinician's point of view.
J.C. Pietté(Sorbonne Université), P Godeau(Normandie Université), O Blétry(Université Paris Cité), P. Cacoub(Sorbonne Université), Lê Thi Huong Dû, R. Laraki, T. Papo(Assistance Publique – Hôpitaux de Paris), B. Wechsler(King's College London), C. Françès(Navarre Institute of Health Research)
PubMed
January 1, 1992
Cited by 5
Related Papers
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Pacemaker infective endocarditis
|The American Journal of Cardiology|1998|314
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
|Lara D. Veeken|2007|301
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262